BTK, a crucial component of the B-cell receptor (BCR) signaling pathway, leading to downstream activation of NF-κB, is essential for ABC (or non-GCB) DLBCL cell survival [155] (Fig. 6). Here, BCR is linked to diffuse large B-cell lymphoma.